Long-term clinical consequences of acute kidney injury in the HIV-infected

• Published in: Kidney international Vol. 78; no. 5; pp. 478 - 485
• Main Authors: Choi, Andy I., Li, Yongmei, Parikh, Chirag, Volberding, Paul A., Shlipak, Michael G.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2010; Elsevier Limited
• Subjects: acute kidney injury; Acute Kidney Injury - etiology; Adult; cardiovascular disease; Cardiovascular Diseases - etiology; end-stage renal disease; Female; HIV; HIV Infections - complications; Human immunodeficiency virus; Humans; Kidney Failure, Chronic - etiology; Male; Middle Aged; mortality; Proportional Hazards Models; mortality; cardiovascular disease; acute kidney injury; HIV; end-stage renal disease
• ISSN: 0085-2538; 1523-1755
• DOI: 10.1038/ki.2010.171

To evaluate the long-term consequences of acute kidney injury (AKI) in human immunodeficiency virus (HIV)-infected persons, we studied 17,325 patients in a national HIV registry during their first hospitalization. We determined the association of AKI with risk for heart failure, cardiovascular events, end-stage renal disease (ESRD), and mortality beginning 90 days after discharge. Based on AKI Network criteria, 2453 had stage 1; 273 had stage 2 or 3; and 334 had dialysis-requiring AKI. Over a mean follow-up period of 5.7 years, 333 had heart failure, 673 had cardiovascular diseases (CVDs), 348 developed ESRD, and 8405 deaths occurred. In multivariable-adjusted analyses, AKI stage 1 was associated with death and ESRD, but not heart failure or other CVD. Dialysis-requiring AKI had much stronger and significant associations with increased risk for long-term ESRD, and death in addition to heart failure and cardiovascular events. When AKI was reclassified to account for recovery, stage 1 with recovery was still associated with death, but not ESRD. Thus, in this national sample of HIV-infected persons, we found the clinical repercussions of AKI appear to extend beyond the hospital setting contributing to excess cardiovascular risks, ESRD, and mortality. Additionally, AKI affected almost one of six patients with HIV who survived at least 90 days following discharge.